Nice article by Ganes Kesari in Forbes this morning about how Unlearn.AI uses digital twins to accelerate clinical trials. forbes.com/sites/ganeskes…

Unlearn.AI is one of several DCVC cos making better, safer, less expensive medicines available dramatically faster. Its ‘digital twin’ of a human patient is a huge breakthrough for the faster, more accurate, less expensive trials we need. forbes.com/sites/ganeskes…

Couldn’t agree more! cc Michelle Wong

It's Day 1 of #CTAD21! Visit our virtual partner space and watch Symposium RS4, featuring chair Jeffrey Cummings and presenters Alejandro Schuler of Unlearn.AI and Stanford University, @PappKate of Brigham and Women's Neurology and Harvard Medical School, and Steven Chance of Oxford Brain Diagnostics. #Alzheimers CTAD

“California is about to take a big step backward by setting up huge barriers for consumers to adopt solar power,” writes Arnold Schwarzenegger, a former governor of the state. nyti.ms/3FDOxxR

“Using #digitaltwins in the design and analysis of a clinical trial maintains the highest standard of evidence while reducing the number of required patients." VentureBeat writes about Unlearn.AI's partnership with Merck KGaA, Darmstadt, Germany. bit.ly/3uXkv6M

We're excited to announce that the European Medicines Agency has published a draft qualification opinion on our patent-pending PROCOVA™ method developed by Unlearn.AI. Read founder & CEO @charleskfisher's blog to learn about this important milestone: bit.ly/3iU3wem

Check out the current edition of JCS to read the article “Artificial Intelligence in Clinical Research,” authored by Unlearn’s Luis Olmos and Dana Jasek to learn how the adoption of #AI-based approaches is steadily increasing within biopharma companies. bit.ly/3ua86LG

Don’t be a Gary

x.com/pt/status/1552…

Come be my Director and oversee the cool methodologies we’re working on! Hiring for other roles in research and applied biostats, machine learning, and others

Apropos to nothing, my general heuristic is to assume that CEOs messaging in bad faith implies position of weakness/vulnerability. The more absurd the argument, the worse things probably are. YMMV.

Breaking News! Unlearn is the first company to receive EU Medicines Agency regulatory approval for a machine learning-based method for reducing sample size in pivotal #clinicaltrials. Read the press release here: bwnews.pr/3dMMbF4

We’re excited to announce the EU Medicines Agency qualification of our PROCOVA™ framework to run TwinRCTs™— trials with smaller control arms. This historic milestone helps pave the way for using #AI to run more patient-centric #clinicaltrials. Read more: bwnews.pr/3dMMbF4

This is The Way

Bay Lights is perhaps my favorite piece of art. By chance, I happened to be running on the Embarcadero one of the first times it was illuminated. The experience was breathtaking and unforgettable. Here's hoping we make Bay Lights 360 a reality. ✨ sfchronicle.com/sf/bayarea/hea…

I support the Mensarius Oath for ethical investing. Founders, and the rest of the startup ecosystem, deserve and need ethical investors. govclab.com/the-mensarius-… #MensariusOath